EconPapers    
Economics at your fingertips  
 

Details about Anirban Basu

E-mail:
Homepage:http://faculty.washington.edu/basua
Workplace:University of Washington -Depts of Pharmacy, Health Services, Economics

Access statistics for papers by Anirban Basu.

Last updated 2017-05-14. Update your information in the RePEc Author Service.

Short-id: pba977


Jump to Journal Articles Software Items

Working Papers

2017

  1. Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads
  2. Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads

2016

  1. Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads

2014

  1. Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads
  2. The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (4)
  3. Welfare Implications of Learning Through Solicitation versus Diversification in Health Care
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads
    See also Journal Article in Journal of Health Economics (2015)

2012

  1. Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (1)

2011

  1. Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (7)
    See also Journal Article in Journal of Health Economics (2011)
  2. Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality
    Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York Downloads
    Also in Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York (2011) Downloads

2010

  1. The Impact of Comparative Effectiveness Research on Health and Health Care Spending
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (6)
    See also Journal Article in Journal of Health Economics (2011)

2009

  1. Estimating Lifetime or Episode-of-illness Costs
    Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York Downloads

2008

  1. The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads
  2. Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads View citations (1)
    Also in Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York (2008) Downloads View citations (1)

2007

  1. Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients
    Health, Econometrics and Data Group (HEDG) Working Papers, HEDG, c/o Department of Economics, University of York Downloads View citations (11)

2003

  1. Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data
    Working Papers, Harris School of Public Policy Studies, University of Chicago Downloads
    Also in NBER Technical Working Papers, National Bureau of Economic Research, Inc (2003) Downloads View citations (2)

    See also Journal Article in Journal of Health Economics (2005)

Journal Articles

2017

  1. Measuring the Value of Pharmaceuticals in the US Health System
    PharmacoEconomics, 2017, 35, (1), 1-4 Downloads

2015

  1. Person-centered treatment (PeT) effects: Individualized treatment effects using instrumental variables
    Stata Journal, 2015, 15, (2), 397-410 Downloads
  2. Welfare implications of learning through solicitation versus diversification in health care
    Journal of Health Economics, 2015, 42, (C), 165-173 Downloads
    See also Working Paper (2014)

2014

  1. CAN WE MAKE SMART CHOICES BETWEEN OLS AND CONTAMINATED IV METHODS?
    Health Economics, 2014, 23, (4), 462-472 Downloads View citations (1)
  2. ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS
    Journal of Applied Econometrics, 2014, 29, (4), 671-691 Downloads View citations (5)
  3. HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH
    Health Economics, 2014, 23, (3), 359-373 Downloads
  4. RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION”
    Health Economics, 2014, 23, (3), 376-378 Downloads

2013

  1. HIGHLIGHTING DIFFERENCES BETWEEN CONDITIONAL AND UNCONDITIONAL QUANTILE REGRESSION APPROACHES THROUGH AN APPLICATION TO ASSESS MEDICATION ADHERENCE
    Health Economics, 2013, 22, (9), 1052-1070 Downloads View citations (18)
  2. Personalized Medicine in the Context of Comparative Effectiveness Research
    Forum for Health Economics & Policy, 2013, 16, (2), 107-120 Downloads

2012

  1. Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials
    PharmacoEconomics, 2012, 30, (10), 859-868 Downloads

2011

  1. Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care
    Journal of Health Economics, 2011, 30, (3), 549-559 Downloads View citations (6)
    See also Working Paper (2011)
  2. Erratum: Estimating lifetime or episode‐of‐illness costs under censoring
    Health Economics, 2011, 20, (1), 125-126 Downloads
  3. The impact of comparative effectiveness research on health and health care spending
    Journal of Health Economics, 2011, 30, (4), 695-706 Downloads View citations (9)
    See also Working Paper (2010)

2010

  1. Estimating lifetime or episode‐of‐illness costs under censoring
    Health Economics, 2010, 19, (9), 1010-1028 Downloads View citations (1)

2009

  1. A linear index for predicting joint health-states utilities from single health-states utilities
    Health Economics, 2009, 18, (4), 403-419 Downloads View citations (1)

2008

  1. Social costs of robbery and the cost-effectiveness of substance abuse treatment
    Health Economics, 2008, 17, (8), 927-946 Downloads View citations (6)
  2. Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling
    Journal of Health Economics, 2008, 27, (3), 531-543 Downloads View citations (235)

2007

  1. Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients
    Health Economics, 2007, 16, (11), 1133-1157 Downloads View citations (44)

2006

  1. Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity
    Health Economics, 2006, 15, (10), 1091-1107 Downloads View citations (6)

2005

  1. Extended generalized linear models: Simultaneous estimation of flexible link and variance functions
    Stata Journal, 2005, 5, (4), 501-516 Downloads View citations (6)
  2. Generalized modeling approaches to risk adjustment of skewed outcomes data
    Journal of Health Economics, 2005, 24, (3), 465-488 Downloads View citations (74)
    See also Working Paper (2003)
  3. Implications of spillover effects within the family for medical cost-effectiveness analysis
    Journal of Health Economics, 2005, 24, (4), 751-773 Downloads View citations (21)

2004

  1. Comparing alternative models: log vs Cox proportional hazard?
    Health Economics, 2004, 13, (8), 749-765 Downloads View citations (17)

2002

  1. Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients?
    RAND Journal of Economics, 2002, 33, (3), 447-468 View citations (19)

Software Items

2014

  1. IVCHECK: Stata module to choose between OLS and contaminated IV
    Statistical Software Components, Boston College Department of Economics Downloads
 
Page updated 2017-10-23